仟源医药：股东拟减持公司不超3%股份

Group 1 - The core point of the article is that Qianyuan Pharmaceutical (300254) announced a plan for a major shareholder to reduce their stake in the company [1] - The shareholder, Weng Zhangguo, who holds 6.16% of the shares, intends to reduce their holdings by up to 7.6831 million shares, which represents 3% of the company's total equity [1] - The reduction will take place within three months after a 15 trading day period, utilizing centralized bidding and block trading methods [1]